Related Experiment Video
Updated: Jul 15, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
PAC1 is a direct transcription target of E2F-1 in apoptotic signaling
1Department of Radiation Oncology, Center for Radiological Research, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
Abstract:
E2F-1 controls multiple cellular activities through transcriptional regulation of its target genes. As a mediator of cell death, E2F-1 can eliminate latent neoplastic cells through apoptosis. However, the mechanism by which E2F-1 mediates cancer cell killing is largely unknown. In this paper, we report that phosphatase of activated cells 1 (PAC1) phosphatase is a direct transcription target of E2F-1 in signaling apoptosis. We show that ectopic E2F-1 increases expression of PAC1 at both transcriptional and translational levels in breast cancer cells. E2F-1 physically interacts with the promoter of PAC1, binds to its consensus sequence in the promoter and transactivates the PAC1 promoter. E2F-1 suppresses extracellular signal-regulated kinase (ERK) phosphorylation through PAC1 and causes cancer cell death by apoptosis following treatment with a chemotherapeutic agent N-4-hydroxyphenylretinamide (4-HPR). Furthermore, ectopic PAC1 inhibits ERK phosphorylation and mediates cell killing. Moreover, endogenous E2F-1 upregulates PAC1 and suppresses ERK activity, leading to cell death in response to 4-HPR. These results reveal a crucial role of PAC1 in E2F-1-directed apoptosis. Our study demonstrates that E2F-1 mediates apoptosis through transcriptional regulation of PAC1 and subsequent suppression of the ERK signaling. Our findings establish a functional link between E2F-1 and mitogen-activated protein kinases. The E2F-1-PAC1 cascade in cancer cell killing may provide a molecular basis for cancer therapeutic intervention.
Insights
The transcription factor E2F-1 directly targets PAC1 phosphatase, initiating apoptosis in cancer cells. This E2F-1-PAC1 pathway suppresses ERK signaling, leading to cancer cell death and offering therapeutic insights.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- E2F-1 regulates cellular activities and mediates apoptosis.
- The precise mechanism of E2F-1 in cancer cell killing remains unclear.
Purpose of the Study:
- To elucidate the mechanism by which E2F-1 induces cancer cell death.
- To identify direct transcriptional targets of E2F-1 involved in apoptosis signaling.
Main Methods:
- Investigated the transcriptional regulation of PAC1 by E2F-1 in breast cancer cells.
- Analyzed E2F-1 interaction with the PAC1 promoter using chromatin immunoprecipitation assays.
- Assessed the role of PAC1 and ERK phosphorylation in E2F-1-mediated apoptosis via Western blotting and cell viability assays.
Main Results:
- Ectopic E2F-1 upregulates PAC1 expression transcriptionally and translationally.
- E2F-1 directly binds to the PAC1 promoter, enhancing its transcription.
- E2F-1, via PAC1, suppresses ERK phosphorylation, inducing apoptosis in response to 4-HPR.
Conclusions:
- PAC1 phosphatase is a direct transcriptional target of E2F-1, crucial for apoptosis.
- The E2F-1-PAC1 cascade suppresses ERK signaling, mediating cancer cell death.
- This pathway provides a potential molecular target for cancer therapeutic interventions.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Cell Specific Gene Expression
MAPK Signaling Cascades
Apoptosis
Caspases
